Bronchiolitis obliterans syndrome after (heart-) lung transplantation: Impaired antiprotease defense and increased oxidant activity

American Journal of Respiratory and Critical Care Medicine

Volumn 160, Issue 5 I, 1999, Pages 1640-1646

  Hirsch, Jan ^b   Elssner, Andreas ^b   Mazur, Gerti ^b   Maier, Konrad L ^b   Bittmann, Iris ^b   Behr, Jürgen ^b   Schwaiblmair, Martin ^b   Reichenspurner, Hermann ^b   Fürst, Heiner ^b   Briegel, Josef ^b   Vogelmeier, Claus ^a  

^a UNIVERSITY OF MUNICH   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ANTITRYPSIN; METHIONINE; MYELOPEROXIDASE; PROTEINASE INHIBITOR; REACTIVE OXYGEN METABOLITE; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ARTICLE; BRONCHIOLITIS; BRONCHOSCOPY; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FORCED EXPIRATORY VOLUME; HEART LUNG TRANSPLANTATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; LUNG FUNCTION; LUNG LAVAGE; NEUTROPHIL; PRIORITY JOURNAL; SPIROMETRY; TRANSBRONCHIAL BIOPSY;

EID: 0032698107     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/ajrccm.160.5.9902012     Document Type: Article

References (35)

1. Hosenpud, J. D., L. E. Bennett, B. M. Keck, B. Fiol, and R. J. Novick. 1997. The Registry of the International Society for Heart and Lung Transplantation: fourteenth official report-1997. J. Heart Lung Transplant 16:691-712.
2. Trulock, E. P. 1997. Lung transplantation. Am. J. Respir. Crit. Care Med. 155:789-818.
3. Allen, M. D., C. M. Burke, C. G. McGregor, J. C. Baldwin, S. W. Jamieson, and J. Theodore. 1986. Steroid-responsive bronchiolitis after human heart-lung transplantation. J. Thorac. Cardiovasc. Surg. 92(3, Pt. 1):449-451.
4. Bando, K., I. L. Paradis, K. Komatsu, H. Konishi, M. Matsushima, R. J. Keena, R. L. Hardesty, J. M. Armitage, and B. P. Griffith. 1995. Analysis of time-dependent risks for infection, rejection, and death after pulmonary transplantation. J. Thorac. Cardiovasc. Surg. 109:49-57.
5. Kramer, M. R., C. Stoehr, J. L. Whang, G. J. Berry, R. Sibley, S. E. Marshall, G. M. Patterson, V. A. Starnes, and J. Theodore. 1993. The diagnosis of obliterative bronchiolitis after heart-lung and lung transplantation: low yield of transbronchial lung biopsy. J. Heart Lung Transplant. 12:675-681.
6. Cooper, J. D., M. Billingham, T. Egan, M. I. Hertz, T. Higenbottam, J. Lynch, J. Mauer, I. Paradis, G. A. Patterson, C. Smith, E. P. Trulock, C. Vreim, and S. Yousem. 1993. A working formulation for the standardization of nomenclature and for clinical staging of chronic dysfunction in lung allografts: International Society for Heart and Lung Transplantation. J Heart Lung Transplant. 12:713-716.
7. Yousem, S. A., G. J. Berry, P. T. Cagle, D. Chamberlain, A. N. Husain, R. H. Hruban, A. Marchevsky, N. P. Ohori, J. Ritter, S. Stewart, and H. D. Tazelaar. 1996. Revision of the 1990 working formulation for the classification of pulmonary allograft rejection: Lung Rejection Study Group. J. Heart Lung Transplant. 15:1-15.
8. Hubbard, R. C., and R. G. Crystal. 1991. Antiproteases. In R. G. Crystal and J. B. West, editors. The Lung. Raven Press, New York. 1775-1787.
9. Di Giovine, B., J. P. I. Lynch, F. J. Martinez, A. Flint, R. T. Whyte, M. D. Iannettoni, D. A. Arenberg, M. D. Burdick, M. C. Glass, C. A. Wilke, S. B. Morris, S. L. Kunkel, and R. M. Strieter. 1996. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J. Immunol. 157:4194-4202.
10. Vogelmeier C., R. C. Hubbard, G. A. Fells, H. P. Schnebli, R. C. Thompson, H. Fritz, and R. G. Crystal. 1991. Anti-neutrophil elastase defense of the normal human respiratory epithelial surface provided by the secretory leukoprotease inhibitor. J. Clin. Invest. 87:482-488.
11. Nadziejko, C., I. Finkelstein, and J. R. Balmes. 1995. Contribution of secretory leukocyte proteinase inhibitor to the antiprotease defense system of the peripheral lung: effect of ozone-induced acute inflammation. Am. J. Respir. Crit. Care Med. 152(5, Pt. 1):1592-1598.
12. Rennard, S. I. 1986. Estimation of volume of epithelial lining fluid by lavage using urea as marker of dilution. J. Appl. Physiol. 60:532-538.
13. Jones, K. P., J. H. Edwards, S. P. Reynolds, T. U. Peters, and B. H. Davies. 1990. A comparison of albumin and urea as reference markers in bronchoalveolar lavage fluid from patients with idiopathic pulmonary fibrosis. Eur. Respir. J. 3:152-156.
14. Ogushi, F., G. A. Fells, R. C. Hubbard, S. D. Straus, and R. G. Crystal. 1987. Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase. J. Clin. Invest. 80:1366-1374.
15. Michalski, J. P., C. C. McCombs, S. Sheth, M. McCarthy, and R. de-Shazo. 1985. A modified double antibody sandwich enzyme-linked immunosorbent assay for measurement of alpha-1-antitrypsin in biologic fluids. J. Immunol. Methods 83:101-112.
16. Dreher, M., G. Gunzer, R. Helger, and H. Lang. 1989. An automated homogeneous enzyme immunoassay for human PMN elastase. Prog. Clin. Biol. Res. 308:707-710.
17. Gross, E. 1967. The cyanogen bromide reaction. Methods Enzymol. 11: 238-255.
18. Maier, K. L., L. Leuschel, and U. Costabel. 1991. Increased levels of oxidized methionine residues in bronchoalveolar lavage fluid proteins from patients with idiopathic pulmonary fibrosis. Am. Rev. Respir. Dis. 143:271-274.
19. Bland, M. 1995. An Introduction to Medical Statistics, 2nd ed. Oxford University Press, Oxford, New York, Tokyo.
20. Braun, J., K. Dalhoff, B. Schaaf, W. G. Wood, and K. J. Wiessmann. 1994. Characterization of protein antiproteinase imbalance in bronchoalveolar lavage from patients with pneumonia. Eur. Respir. J. 7:127-133.
21. Birrer, P., N. G. McElvaney, A. Rudeberg, C. W. Sommer, G. S. Liechti, R. Kraemer, R. Hubbard, and R. G. Crystal. 1994. Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150:207-213.
22. Kindt, G. C., J. E. Weiland, W. B. Davis, J. E. Gadek, and P. M. Dorinsky. 1989. Bronchiolitis in adults: a reversible cause of airway obstruction associated with airway neutrophils and neutrophil products. Am. Rev. Respir. Dis. 140:483-492.
23. Nunley, D., J. Dauber, A. Iacono, R. Keenan, A. Zeevi, R. Cornwell, R. Love, and K. Meyer. 1999. Unopposed neutrophil elastase in bronchoalveolar lavage from transplant recipients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 159:258-261.
24. Hertz, M. I., C. A. Henke, R. E. Nakhleh, K. R. Harmon, W. A. Marinelli, J. M. Fox, S. H. Kubo, S. J. Shumway, R. D. Bolman, and P. B. Bitterman. 1992. Obliterative bronchiolitis after lung transplantation: a fibroproliferative disorder associated with platelet-derived growth factor. Proc. Natl. Acad. Sci. U.S.A. 89:10385-10389.
25. Magnan, A., J. L. Mege, J. C. Escallier, J. Brisse, C. Capo, M. Reynaud, P. Thomas, B. Meric, L. Garbe, M. Badier, L. Viard, P. Bongrand, R. Giudicelli, D. Metras, P. Fuentes, D. Vervloet, and M. Noirclerc. 1996. Balance between alveolar macrophage IL-6 and TGF-beta in lung-transplant recipients: Marseille and Montreal Lung Transplantation Group. Am. J. Respir. Crit. Care Med. 153:1431-1436.
26. Abbinante-Nissen, J. M., L. G. Simpson, and G. D. Leikauf. 1995. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 268(4, Pt. 1): 1601-1606.
27. Magnan, A., J. L. Mege, M. Reynaud, P. Thomas, C. Capo, L. Garbe, B. Meric, M. Badier, P. Bongrand, L. Viard, D. Metras, R. Giudicelli, and M. Noirclevc. 1994. Monitoring of alveolar macrophage production of tumor necrosis factor-alpha and interleukin-6 in lung transplant recipients: Marseille and Montreal Lung Transplantation Group. Am. J. Respir. Crit. Care Med. 150:684-689.
28. Kramps, J. A., C. van Twisk, E. C. Klasen, and J. H. Dijkman. 1988. Interactions among stimulated human polymorphonuclear leucocytes, released elastase and bronchial antileucoprotease. Clin. Sci. 75:53-62.
29. Masuda, K., T. Suga, A. Takeuchi, M. Kanesaki, A. Imaizumi, and Y. Suzuki. 1994. Specific cleavage of secretory leukoprotease inhibitor by neutrophil elastase and saliva. Biochem. Phamacol. 48:651-657.
30. Wasil, M., B. Halliwell, D. C. Hutchison, and H. Baum. 1987. The antioxidant action of human extracellular fluids: effect of human serum and its protein components on the inactivation of alpha 1-antiproteinase by hypochlorous acid and by hydrogen peroxide. Biochem. J. 243: 219-223.
31. Davis, W. B., and E. R. Pacht. 1991. Extracellular antioxidant defenses. In R. G. Crystal and J. B. West, editors. The Lung. Raven Press, New York. 1821-1827.
32. Warren, J. S., K. J. Johnson, and P. A. Ward. 1991. Consequences of oxidant injury. In R. G. Crystal and J. B. West, editors. The Lung. Raven Press, New York. 1829-1838.
33. Flich, M. A., A. Perel, and N. C. Staub. 1981. Leukocytes are required for increased lung microvascular permeability after microembolization in sheep. Circ. Res. 48:344-351.
34. Shasby, D. M., R. M. Vanbenthuysen, R. M. Tate, S. S. Shasby, I. F. McMurty, and J. E. Repine. 1982. Granulocytes mediate acute edematous lung injury in rabbits and isolated rabbit lungs perfused with phorbol myristate acetate: role of oxygen radicals. Am. Rev. Respir. Dis. 125:443-447.
35. Gilliard, N., G. P. Heldt, J. Loredo, H. Gasser, H. Redl, T. A. Merritt, and R. G. Spragg. 1994. Exposure of the hydrophobic components of porcine lung surfactant to oxidant stress alters surface tension properties. J. Clin. Invest. 93:2608-2615.